Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07434713
Recruiting
EarLy Treatment Response in nEoVascular Macular Degeneration With Eylea 8mg: ELEV8 A Prospective Observational Open Label Study Investigating the Fluid Dynamics During Early Response to Aflibercept 8mg in Patients With Exudative Age-related Macular Degeneration (AMD).
Not applicable · Switzerland · 1 site
Registry update: 27 Feb 2026
NCT06685211
Recruiting
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
Not applicable · United States · 1 site
Registry update: 9 Oct 2026
NCT07082114
Recruiting
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Phase 3 · China · 1 site
Registry update: 24 Jul 2025
NCT07387432
Recruiting
Role of Exercise in PRISm and Subsequent Development of COPD
Not applicable · China · 1 site
Registry update: 6 Mar 2026
2023-508303-20-01
Recruiting
Evaluation of p-glycoprotein alterations in treatment-resistant depression: a [18F]MC225 PET study
Phase 2 · Italy · 1 site
Registry update: 16 Apr 2025
NCT07015762
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
Phase 1 · China · 1 site
Registry update: 7 Aug 2025
NCT07051850
Recruiting
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
Not applicable · South Korea · 1 site
Registry update: 15 Jul 2025
NCT07114120
Recruiting
Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules
Phase 4 · China · 5 sites
Registry update: 11 Aug 2025
NCT07117656
Recruiting
Project Vuselela Feasibility
Not applicable · South Africa · 1 site
Registry update: 12 Aug 2025
NCT07144332
Recruiting
This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering Therapy
Not applicable · Egypt · 1 site
Registry update: 27 Aug 2025
NCT07056049
Recruiting
The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery
Not applicable · Israel · 1 site
Registry update: 17 Jul 2025
NCT06832722
Recruiting
A Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care.
Phase 1/2 · Armenia, Belgium, Czechia, Germany, Spain, France, Netherlands, Poland, Serbia · 36 sites
Registry update: 14 Sept 2026
NCT07015216
Recruiting
Effects of Virtual Reality-Assisted Dual Task Training on Muscle Oxygenation in Patients With COPD
Not applicable · 1 site
Registry update: 22 Jun 2025
NCT07138144
Recruiting
Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
Phase 4 · Mexico · 1 site
Registry update: 22 Aug 2025
NCT07672821
Recruiting
Time-Restricted Eating After Bariatric Surgery
Not applicable · 1 site
Registry update: 29 Jun 2026
NCT07343271
Recruiting
Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx
Not applicable · France · 1 site
Registry update: 15 Jan 2026
NCT06862206
Recruiting
A Multicentre, Single Arm, Non-interventional, Real-world Study to Assess Demographic Characteristics and Patient Reported Outcomes in Patients With Severe Eosinophilic Asthma Treated With Benralizumab in China
Not applicable · China · 36 sites
Registry update: 9 Nov 2026
2024-516870-31-00
Recruiting
A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors
Phase 1 · Netherlands · 2 sites
Registry update: 28 May 2026
NCT07355075
Recruiting
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Phase 2/3 · United States · 1 site
Registry update: 4 Sept 2026
NCT07059221
Recruiting
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
Phase 1/2 · China · 2 sites
Registry update: 20 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.